Not surprisingly, Canadian pot stocks have been the top performers of late, with Canopy Growth Corp. (NASDAQOTH:TWMJF), the now-largest marijuana stock in the world by market cap, leading the charge.
Tag Archives: Results
CHICAGO, Nov. 1, 2017 /Weed Wire/ — Aclara Research, a leader in the development of patient and consumer insights within the cannabis industry, today released the preliminary results of their latest study examining patient usage of medical cannabis and the impact on prescription opioid usage.
LOS ANGELES, Aug. 15, 2017 /Weed Wire/ — Agritek Holdings, Inc. (OTCQB: AGTK), www.AgritekHoldings.com, a fully integrated, active cannabis real estate investor and branding consultant in the legal cannabis sector, today announced the timely filing of the Company’s second quarter financial results for 2017.
When GW Pharmaceuticals announced its fiscal third-quarter results on Monday, the company provided plenty of information about its performance during the quarter. However, it wasn’t any of the numbers in the update that caused this decline. Instead, one word caused investors’ disappointment.
The results for Canopy Growth’s stock have been terrific so far, yielding a return of over 152% since inception. The stock has been performing well despite lacklustre results and frequent losses.
DENVER, Feb. 17, 2017 /Weed Wire/ — MassRoots, Inc. (OTCQB:MSRT), one of the leading technology platforms for the cannabis industry, announced today a general business update on the Company and legal cannabis marketplace.
LOS ANGELES, July 6, 2016 /Weed Wire/ — Kush Bottles, Inc. (OTCQB: KSHB), America’s premier supplier of packaging, accessories, and branding solutions for the legal cannabis industry, today reported record financial results for its third quarter and nine months ended May 31, 2016 and provided a positive outlook for the balance of the fiscal year and 2017.
EAGLE POINT, Ore., June 17, 2016 /Weed Wire/ — Grow Condos, Inc. (OTC PINK: GRWC), a fully reporting publicly traded company specialized in cannabis industry related “Condo” style real estate and turn-key grow facilities, is pleased to announce that the Company has incorporated an Advisory Board for the purpose of providing the Company and its clients with valuable industry specific guidance and assistance.
HOUSTON, Texas, May 17, 2016 /Weed Wire/ — Indoor Harvest Corp (OTCQB:INQD) is pleased to report first quarter results for 2016.
What would you do if marijuana became legal? According to a new survey, the answer for many Americans: Start a garden.
As a veteran in commercial financing for marijuana businesses, I have seen many business owners struggle to obtain funding.
On March 14, 2016, GW Pharmaceuticals (NASDAQ: GWPH), a biopharma company with two promising cannabis-based medications, announced positive results for the first pivotal Phase 3 study of Epidiolex, a CBD-based medicine, in treating Dravet syndrome, a severe form of pediatric epilepsy.
LONDON, March 14, 2016 /Weed Wire/ — GW Pharmaceuticals plc (Nasdaq:GWPH) (AIM:GWP) (“GW,” “the Company” or “the Group”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, announces the positive results of the first pivotal Phase 3 study of its investigational medicine Epidiolex® (cannabidiol or CBD) for the treatment of Dravet syndrome.
HOUSTON, Sept. 29, 2015 /PRNewswire/ — Indoor Harvest Corp (OTCQB: INQD), (“Indoor Harvest” or the “Company”), is a mechanical design build contractor, developer, marketer and direct-seller of commercial grade aeroponic and hydroponic vertical farming fixtures and supporting systems for use in urban Controlled Environment Agriculture and Building Integrated Agriculture.
Lexaria Corp. (OTCQB: LXRP) is not the average marijuana tech-related startup. For one thing, its founders originally began their careers in oil and gas.
PETACH TIKVA, Israel, June 17, 2015 /PRNewswire/ — OWC Pharmaceutical Research Corp. (OTCQB: OWCP), today announced that its wholly owned subsidiary, One World Cannabis Ltd. (“the Company”), an Israel-based developer of cannabinoid-based therapies targeting a variety of different indications, is proud to announce it has received the first basic science study (lab) results on the effect of several combination of Cannabidiol (CBD) and tetrahydrocannabinol (THC) on multiple myeloma cell line RPMI8226.
Whenever medical marijuana is mentioned, the image of people with chronic pain and other painful illnesses comes to mind. The mainstream image of medical marijuana is that it can help treat pain, nausea, and even epileptic seizures.
Ever earned a $20 bill … on weed? According to a SurveyMonkey poll conducted by Mashable, one in 10 people in the United States have gone to work while high on marijuana. The poll highlights other drug habits of the American worker, and despite lingering questions, the results help contrast the use of prescription drugs to marijuana.
July 31, 2014 | The Brookings Institution released a report today confirming what many Americans already suspected: the rollout of legal marijuana in Colorado is a success.